siRNA, Anti-TSC22D3, LNA-modified(CAT#: SIRGT09233WQ-LNA)

The product SIRGT09233WQ-LNA is a type of small interfering RNA (siRNA) that targets TSC22D3 gene and regulates the expression of gene. The siRNA interferes with the expression of TSC22D3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001015881.1; NM_001318468.1; NM_001318470.1; NM_004089.3; NM_198057.2
Alternative Names DIP; DSIPI; GILZ; TSC-22R
Related Diseases Glucocorticoid-Induced Osteoporosis
Purification HPLC
Target Gene
Gene ID 1831
Uniprot ID Q99576

Related Products